102 related articles for article (PubMed ID: 3674659)
1. Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis.
Crockett DM; McCabe BF; Lusk RP; Mixon JH
Ann Otol Rhinol Laryngol; 1987; 96(5):601-7. PubMed ID: 3674659
[TBL] [Abstract][Full Text] [Related]
2. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
[TBL] [Abstract][Full Text] [Related]
3. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.
Leventhal BG; Kashima HK; Weck PW; Mounts P; Whisnant JK; Clark KL; Cohen S; Dedo HH; Donovan DJ; Fearon BW
Arch Otolaryngol Head Neck Surg; 1988 Oct; 114(10):1163-9. PubMed ID: 3046638
[TBL] [Abstract][Full Text] [Related]
4. [The combined treatment of juvenile outset recurrent respiratory papillomatosis].
Xie J; Dong P; Li K; Wang J; Jin B; Zhang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Nov; 20(21):975-7. PubMed ID: 17219994
[TBL] [Abstract][Full Text] [Related]
5. [The interferon status and circulating immunoglobulins during the interferon therapy of respiratory papillomatosis in children].
Pritsker AD; Grigorian SS; Onufrieva SS; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):411-4. PubMed ID: 1725077
[TBL] [Abstract][Full Text] [Related]
6. [The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis].
Grigorian SS; Pritsker AD; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):407-9. PubMed ID: 1803775
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.
Healy GB; Gelber RD; Trowbridge AL; Grundfast KM; Ruben RJ; Price KN
N Engl J Med; 1988 Aug; 319(7):401-7. PubMed ID: 3398891
[TBL] [Abstract][Full Text] [Related]
8. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions.
Kashima H; Leventhal B; Clark K; Cohen S; Dedo H; Donovan D; Fearon B; Gardiner L; Goepfert H; Lusk R
Laryngoscope; 1988 Mar; 98(3):334-40. PubMed ID: 3278186
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of alpha-interferon dose variation on laryngeal papillomas.
Mullooly VM; Abramson AL; Steinberg BM; Horowitz MS
Laryngoscope; 1988 Dec; 98(12):1324-9. PubMed ID: 3200075
[TBL] [Abstract][Full Text] [Related]
10. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V; Rastorguev E; Gerein J; Lodemann E; Pfister H; Draf W; Desloovere C
J Laryngol Otol; 2004 Oct; 118(10):750-6. PubMed ID: 15550179
[TBL] [Abstract][Full Text] [Related]
11. Interferon and laryngeal papillomatosis. The Iowa experience.
McCabe BF; Clark KF
Ann Otol Rhinol Laryngol; 1983; 92(1 Pt 1):2-7. PubMed ID: 6824274
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.
Zenner HP; Kley W; Clarós P; Clarós A; Labas Z; Löbe LP; Pavelka R; Plath P; Ribari O; Niethammer D
Oncology; 1985; 42 Suppl 1():15-8. PubMed ID: 3909032
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent respiratory papillomatosis with interferon.
Sessions RB; Dichtel WJ; Goepfert H
Ear Nose Throat J; 1984 Oct; 63(10):488-93. PubMed ID: 6489206
[No Abstract] [Full Text] [Related]
14. Recurrent respiratory papillomatosis.
Tasca RA; Clarke RW
Arch Dis Child; 2006 Aug; 91(8):689-91. PubMed ID: 16861486
[TBL] [Abstract][Full Text] [Related]
15. [Natural killer activity in respiratory papillomatosis and its changes after interferon treatment].
Pritsker AD; Grigorian SS; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):409-11. PubMed ID: 1803776
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis.
Rosen CA; Woodson GE; Thompson JW; Hengesteg AP; Bradlow HL
Otolaryngol Head Neck Surg; 1998 Jun; 118(6):810-5. PubMed ID: 9627242
[TBL] [Abstract][Full Text] [Related]
17. Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
Thurmond LM; Brand CM; Leventhal BG; Finter NB; Johnston JM
J Lab Clin Med; 1991 Sep; 118(3):232-40. PubMed ID: 1919296
[TBL] [Abstract][Full Text] [Related]
18. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
[TBL] [Abstract][Full Text] [Related]
19. Three-year experience of treating recurrent respiratory papilloma with interferon.
Lusk RP; McCabe BF; Mixon JH
Ann Otol Rhinol Laryngol; 1987; 96(2 Pt 1):158-62. PubMed ID: 3551741
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis.
Silver RD; Rimell FL; Adams GL; Derkay CS; Hester R
Otolaryngol Head Neck Surg; 2003 Dec; 129(6):622-9. PubMed ID: 14663426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
